Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.
about
Association of cystatin C with mortality, cardiovascular events, and incident heart failure among persons with coronary heart disease: data from the Heart and Soul StudyImplication of hepatokines in metabolic disorders and cardiovascular diseasesType 2 Diabetes in Non-Alcoholic Fatty Liver Disease and Hepatitis C Virus Infection--Liver: The "Musketeer" in the SpotlightThe role of fetuin-A in mineral trafficking and depositionDietary oil modifies the plasma proteome during aging in the ratAssociation of fetuin-A with mitral annular calcification and aortic stenosis among persons with coronary heart disease: data from the Heart and Soul StudyMarked defects in the expression and glycosylation of alpha2-HS glycoprotein/fetuin-A in plasma from neonates with intrauterine growth restriction: proteomics screening and potential clinical implications.Fetuin-A induces cytokine expression and suppresses adiponectin production.Association of serum phosphorus with left ventricular mass in men and women with stable cardiovascular disease: data from the Heart and Soul Study.AMP-activated Protein Kinase (AMPK): Does This Master Regulator of Cellular Energy State Distinguish Insulin Sensitive from Insulin Resistant Obesity?Adipokine pattern in subjects with impaired fasting glucose and impaired glucose tolerance in comparison to normal glucose tolerance and diabetesEffect of ezetimibe on hepatic fat, inflammatory markers, and apolipoprotein B-100 kinetics in insulin-resistant obese subjects on a weight loss dietRole of fetuin A in the diagnosis and treatment of joint arthritis.Psychological risk factors and the metabolic syndrome in patients with coronary heart disease: findings from the Heart and Soul Study.Serum fetuin-A associates with type 2 diabetes and insulin resistance in Chinese adultsCirculating alanine transaminase (ALT) and γ-glutamyl transferase (GGT), but not fetuin-A, are associated with metabolic risk factors, at baseline and at two-year follow-up: the prospective Cyprus Metabolism Study.Plasma fetuin-A concentrations in young and older high- and low-active men.Associations of fetuin-A levels with vascular disease in type 2 diabetes patients with early diabetic nephropathy.Fetuin-A levels are increased in patients with type 2 diabetes and peripheral arterial diseaseInflammatory and metabolic biomarkers and risk of liver and biliary tract cancer.Interaction between plasma fetuin-A and free fatty acids predicts changes in insulin sensitivity in response to long-term exerciseAssociations of fetuin-A and osteoprotegerin with arterial stiffness and early atherosclerosis in chronic hemodialysis patients.Relationship between serum levels of fetuin-A with apo-A1, apo-B100, body composition and insulin resistance in patients with type 2 diabetesHepatokines as a Link between Obesity and Cardiovascular Diseases.The effects of omega-3 fatty acid on vitamin D activation in hemodialysis patients: a pilot studyBiomarkers of insulin sensitivity and insulin resistance: Past, present and future.Impact of Virgin Olive Oil and Phenol-Enriched Virgin Olive Oils on the HDL Proteome in Hypercholesterolemic Subjects: A Double Blind, Randomized, Controlled, Cross-Over Clinical Trial (VOHF Study).The relationship of circulating fetuin-a with liver histology and biomarkers of systemic inflammation in nondiabetic subjects with nonalcoholic fatty liver disease.Mechanisms linking obesity, chronic kidney disease, and fatty liver disease: the roles of fetuin-A, adiponectin, and AMPK.Usefulness of fetuin-A to predict risk for cardiovascular disease among patients with obstructive sleep apnea.Fetuin-A Characteristics during and after Pregnancy: Result from a Case Control Pilot Study.The association of fetuin-A with cardiovascular disease mortality in older community-dwelling adults: the Rancho Bernardo study.Relationship between Fetuin A, Vascular Calcification and Fracture Risk in Dialysis Patients.Association of fetuin-a with incident diabetes mellitus in community-living older adults: the cardiovascular health study.Fetuin-A and risk of coronary heart disease: A Mendelian randomization analysis and a pooled analysis of AHSG genetic variants in 7 prospective studiesThe association between circulating fetuin-A levels and type 2 diabetes mellitus risk: systematic review and meta-analysis of observational studies.Fetuin-A levels in obesity: differences in relation to metabolic syndrome and correlation with clinical and laboratory variablesBiomarkers to predict recurrent cardiovascular disease: the Heart and Soul Study.Plasma levels of fetuin-A and hepatic enzymes and risk of type 2 diabetes in women in the U.S.Serum fetuin-A levels related with microalbuminuria in diet-induced obese rats.
P2860
Q24646339-A3AB6EA2-217F-4E82-805D-24096421DEFBQ26751147-966093E7-328C-4FC5-831B-9B1CD12C05CFQ26752583-6E45D8A7-8CA6-49EB-B58A-0572B358F8A5Q27021447-35B11D16-29D8-46F7-993F-070E005CE16CQ28569420-AFABF0E6-129A-4C51-9540-A74F6B5F10C3Q31111874-713FC308-A393-4A92-838A-D29DBA2E2675Q33309151-92F1F0EC-7CCB-4290-92E1-BCFFD644C466Q33323370-86B6FDB5-4F76-4325-BAB5-5774DF7B7BCFQ33617174-12F7B4E7-6A62-43A5-8CC0-73CF082AF77BQ33688657-4357A57A-188D-4CA1-BEB7-50E2DD2547B9Q33749786-F80137C7-74AF-458F-905F-378C15AC3F4BQ33804734-E4F9645D-575D-4A15-96D4-1846F93A2D7DQ33818400-93940D08-40ED-42C9-AFE4-410FE1992701Q33842504-7BE69449-9A83-43B1-9ABC-111B4A4BE2F3Q33893894-C4E8CA53-1A2D-4893-80B0-A608D120D15EQ33924942-B7C14437-941A-42D5-A676-7C940865D52CQ33976378-D60F11F0-F030-4099-BAC6-4C386D679191Q34173840-5ABEDBB1-B2B4-4C78-BB52-70C3DBEE48EEQ34421909-F36691D4-6275-4291-9338-13D116D7AE47Q34511085-96099FF1-0EA4-402C-A784-4C5C8E0EAEECQ34680972-7F774EC6-E980-4680-AEB2-3A4ACF8BEA36Q34768588-E883293F-F06E-4FD7-BF6B-943DB044CE59Q34993000-EBC3E006-FA46-487D-985F-1D262F3834A4Q35126823-95D868F3-83CB-4963-A849-88642432B87EQ35131450-7FA73852-12E3-461A-8ECE-F24182C68BFFQ35652813-C6176E3C-5687-4D34-BED9-F4A9CD7E9D72Q35659485-9278E6C5-BD1F-4F85-9A79-F1C477330DE3Q35681974-0ACA56A3-5546-40D5-9D71-2795652693F5Q35757790-B476B964-6BC8-45A3-A8B9-D268076A8B1CQ35762933-8E7EE34F-70CD-45AC-90A0-92780018CC9DQ35875147-1DCCD513-A27E-45F3-B335-63676C845376Q35936268-D90C689E-AFDB-45E4-9CC7-F381A2D70449Q36072533-493462DF-0AA4-408A-B2FC-C734543A1A48Q36079687-A900001C-43EB-45E3-9DE6-8BA2390B1DAEQ36173735-7FCE209A-A61E-4CC0-897F-AA81B10774BCQ36413070-352C0C9D-D71E-47B4-93BB-C7B63422F57FQ36423049-92DCDB20-9CD0-4329-93B3-D481CC271BFCQ36455014-344D39E5-2E82-4406-BC63-38C13C485D1DQ36477337-54CC9449-C6B4-404B-A564-B1FA4CDA5AF9Q36665115-2B1852FA-CD58-4536-8113-6C5C1609A796
P2860
Association between human fetuin-A and the metabolic syndrome: data from the Heart and Soul Study.
description
2006 nî lūn-bûn
@nan
2006 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի մարտին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Association between human fetu ...... from the Heart and Soul Study.
@ast
Association between human fetu ...... from the Heart and Soul Study.
@en
type
label
Association between human fetu ...... from the Heart and Soul Study.
@ast
Association between human fetu ...... from the Heart and Soul Study.
@en
prefLabel
Association between human fetu ...... from the Heart and Soul Study.
@ast
Association between human fetu ...... from the Heart and Soul Study.
@en
P2093
P2860
P50
P1433
P1476
Association between human fetu ...... from the Heart and Soul Study.
@en
P2093
Markus Ketteler
Vincent M Brandenburg
P2860
P304
P356
10.1161/CIRCULATIONAHA.105.588723
P407
P577
2006-03-27T00:00:00Z